Skip to content

Clinical trials

Phase 3 Precursor T-Cell Lymphoblastic Leukemia-Lymphoma trials in the United States

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Precursor T-Cell Lymphoblastic Leukemia-Lymphoma Phase: Phase 3 Country / region: United States Clear all

16 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20003
20011
20031
20051
20061
20072
20082
20141
20171
20231

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed12
Active, not recruiting3
Unknown status1

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Jonsson Comprehensive Cancer Center3
Alliance for Clinical Trials in Oncology2
Children's Oncology Group2
Memorial Sloan Kettering Cancer Center2
National Cancer Institute (NCI)2
Case Comprehensive Cancer Center1
European Organisation for Research and Treatment of Cancer - EORTC1
INSYS Therapeutics Inc1
Mayo Clinic1
Vanderbilt-Ingram Cancer Center1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Precursor T-Cell Lymphoblastic Leukemia-Lymphoma16
Burkitt Lymphoma13
Precursor Cell Lymphoblastic Leukemia-Lymphoma13
Hodgkin Disease12
Leukemia, Lymphocytic, Chronic, B-Cell12
Lymphoma, Follicular12
Lymphoma, Large B-Cell, Diffuse12
Lymphoma, Large-Cell, Immunoblastic12
Lymphoma, Mantle-Cell12
Lymphoma, Non-Hodgkin12

Trials

Showing 1 to 16 of 16. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.